GLP-1 Drug Slows Alzheimerβs Cognitive Decline
30 July 2024 at 21:35
A recent study suggests that a GLP-1 drug, liraglutide, may protect the brains of people with mild Alzheimerβs disease, slowing cognitive decline by 18% over one year. This effect is likely due to the drugβs ability to reduce brain inflammation, improve insulin resistance, and lower the impact of Alzheimerβs biomarkers.